Finding a suitable kidney donor is not simply a matter of matching blood groups. Before a transplant can take place, doctors perform several tests to determine whether the donor kidney is compatible with the recipient and whether the recipient's immune system is likely to react against it.

*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.
The matching process usually considers the donor's and recipient's blood groups, tissue types, antibodies, and crossmatch results. The donor's overall health and the recipient's medical condition are also important when deciding whether a particular kidney is suitable.
A perfect match is not required for every kidney transplant. Modern transplant medicine can successfully use kidneys with varying degrees of tissue matching, provided the overall immunological risk is acceptable and the transplant team has an appropriate management plan. Learn more about kidney transplantation in our Kidney Transplant Surgery guide.
What Does “Matching” Mean in a Kidney Transplant?
Matching refers to the process of comparing characteristics of a potential donor and recipient to determine whether the donor kidney can be safely transplanted. Several different types of compatibility are considered because the immune system can recognise the transplanted kidney as foreign.
The main parts of the assessment include:
- Blood-group compatibility
- HLA or tissue matching
- Antibody testing
- Crossmatch testing
- Overall medical suitability
These tests work together. No single result usually tells the complete story about whether a donor kidney is suitable.
Step 1: Blood Group Matching
Blood-group compatibility is one of the first things checked when assessing a potential kidney donor. The main blood groups are A, B, AB, and O. A recipient's blood group affects which donor kidneys may be compatible.
| Recipient Blood Group | Compatible Donor Blood Groups |
|---|---|
| O | O |
| A | A or O |
| B | B or O |
| AB | A, B, AB or O |
The Rh factor, meaning whether blood is positive or negative, does not determine compatibility for a kidney transplant in the same way it does for blood transfusion.

*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.
Step 2: HLA and Tissue Typing
Blood group is only one part of the matching process. The transplant team also looks at the recipient's human leukocyte antigen (HLA) type.
HLA molecules are markers found on cells that help the immune system distinguish the body's own tissues from foreign tissues. Donors and recipients inherit different combinations of HLA markers, so their tissue types may be more or less similar. The transplant team compares the donor's and recipient's HLA characteristics to understand the degree of tissue matching.
A closer HLA match can be beneficial from an immunological perspective, but a perfect HLA match is not required for most kidney transplants. Modern immunosuppressive treatment allows many kidneys with some degree of HLA mismatch to be transplanted successfully.
Step 3: Antibody Testing
Another important question is whether the recipient already has antibodies that could react against a potential donor kidney. Some people develop antibodies after exposure to foreign tissues through events such as:
- Previous organ transplantation
- Blood transfusions
- Pregnancy
What Does a High Antibody Level Mean?
A person with a high level of antibodies may have fewer compatible donor options than someone who is not highly sensitised.
This does not necessarily mean that transplantation is impossible. Instead, it can make finding a suitable donor more challenging and may increase the importance of specialised matching strategies.
Depending on the transplant system and the individual situation, options may include searching for a more compatible donor, kidney paired donation, or carefully selected approaches for managing incompatibility.
Step 4: The Crossmatch Test
Crossmatching is one of the most important final compatibility checks before transplantation. In a crossmatch, the recipient's blood is tested against cells from the potential donor to determine whether the recipient has antibodies that react strongly against that donor.

*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.
A negative crossmatch generally indicates that the recipient does not have detectable antibodies that would strongly attack the donor's cells in the test.
A positive crossmatch indicates a significant immunological reaction and can mean that the donor kidney is not suitable for direct transplantation under standard circumstances.
The exact testing strategy can vary depending on the transplant centre, the recipient's antibody profile, and the clinical circumstances.
Why Is Crossmatching So Important?
Blood-group compatibility and HLA matching do not provide the complete picture of immune compatibility. A recipient can have antibodies that react specifically against a potential donor's HLA markers.
A crossmatch helps identify this donor-specific immune reaction before transplantation. This is particularly important for sensitised recipients, who may have developed antibodies through previous transplantation, pregnancy, or transfusion.
Does a Perfect Donor Match Exist?
Sometimes donor and recipient can have very similar HLA types, particularly among certain close biological relatives. However, most kidney transplants do not involve a perfect tissue match.
A transplant can still be successful when donor and recipient have HLA differences. The transplant team considers the complete immunological picture rather than expecting every characteristic to be identical.
This is why the term “good match” should not be understood as meaning that every donor characteristic has to be the same as the recipient's.
What If a Living Donor Is Not a Direct Match?
A person may have a willing living donor who is medically suitable but not directly compatible because of blood-group or immunological differences. This does not necessarily mean that the donor-recipient pair has no transplant options.
Kidney Paired Donation
Kidney paired donation, also called paired exchange, can allow incompatible donor-recipient pairs to exchange donors with another incompatible pair. For example, imagine:
- Pair 1: Donor A cannot directly donate to Recipient A.
- Pair 2: Donor B cannot directly donate to Recipient B.
If Donor A is compatible with Recipient B and Donor B is compatible with Recipient A, the two pairs may be able to exchange donors through an appropriate paired-donation programme. This approach can expand living-donor opportunities for some patients who otherwise have an incompatible donor.

*AI-generated image - for illustration only. Clinical accuracy is not guaranteed.
Can Blood-Group-Incompatible Kidney Transplants Be Performed?
In selected circumstances, transplantation across certain blood-group barriers may be possible using specialised approaches to reduce or manage the recipient's antibodies.
However, these procedures require careful assessment because they can involve additional treatment and immunological risks. They are not appropriate for every donor-recipient pair.
The transplant team will determine whether incompatibility management is appropriate or whether another donor-matching strategy would be safer or more suitable.
How Is Matching Different for Living and Deceased Donors?
The basic compatibility principles remain important for both living- and deceased-donor transplantation, but the way kidneys are allocated can differ.
With a living donor, the donor and recipient can undergo detailed compatibility testing in advance. If they are incompatible, there may be time to explore paired donation or other options.
With a deceased donor, a kidney becomes available unexpectedly and needs to be allocated according to the rules of the relevant transplant system. Blood group, tissue characteristics, antibody status, waiting time, and other allocation factors may influence which recipient is offered the kidney.
The Bottom Line
Kidney donor-recipient matching involves much more than checking whether two people have compatible blood groups. The transplant team assesses ABO blood group, HLA or tissue type, antibodies, crossmatch results, and overall medical suitability before deciding whether a donor kidney is appropriate.
A perfect tissue match is not required for most kidney transplants, and an incompatible living donor does not necessarily mean that transplantation is impossible. Paired donation and, in selected circumstances, specialised incompatibility-management strategies may provide additional options.
The goal of matching is not simply to find two people who are identical in every characteristic. It is to identify a donor kidney that can be transplanted with an acceptable level of immunological and medical risk.
Because compatibility can be complex, the final decision is made through detailed testing and assessment by the transplant team rather than through blood-group matching alone.